title: Use of electroconvulsive therapy in an adolescent with systemic lupus erythematosus for management of depression.
abstract: Use of electroconvulsive therapy (ECT) has been infrequently described in patients with systemic lupus erythematosus and is most commonly used in patients with catatonia. In this report, we describe the use of ECT in a young adolescent girl who had bipolar affective disorder associated with systemic lupus erythematosus and was treated with ECT for the depressive episode. The patient achieved remission with a course of 6 ECT treatments.
authors: Department of Psychiatry, Postgraduate Institute of Medical Education and Research, Chandigarh, India. drsandeepg2002@yahoo.com
authors: Sandeep
authors: S
authors: Grover
authors: Krishnan Rajlakshmi
authors: KR
authors: Aarya
authors: Aman
authors: A
authors: Sharma
mesh_terms: D000293:Adolescent; D000477:Alkylating Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001569:Benzodiazepines / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000150:complications / Q000523:psychology; D003511:Cyclohexanols / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D003865:Major Depressive Disorder / Q000150:complications / Q000628:therapy*; D004565:Electroconvulsive Therapy / Q000379:methods*; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000188:drug therapy; D000077152:Olanzapine; D011239:Prednisolone / Q000627:therapeutic use; D000069470:Venlafaxine Hydrochloride
chemical_list: D000477:Alkylating Agents; D000893:Anti-Inflammatory Agents; D018687:Antidepressive Agents, Second-Generation; D014150:Antipsychotic Agents; D003511:Cyclohexanols; D001569:Benzodiazepines; D000069470:Venlafaxine Hydrochloride; D003520:Cyclophosphamide; D011239:Prednisolone; D000077152:Olanzapine